Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer (SOFT)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Breast International Group

Cancer and Leukemia Group B

NCIC Clinical Trials Group

North Central Cancer Treatment Group

National Surgical Adjuvant Breast and Bowel Project (NSABP)

Southwest Oncology Group

Information provided by (Responsible Party):

International Breast Cancer Study Group

ClinicalTrials.gov Identifier:

NCT00066690

First received: August 6, 2003

Last updated: April 10, 2013

Last verified: April 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2013 (Final data collection date for primary outcome measure)